Guiding TRAIL to cancer cells through Kv10.1 potassium channel overcomes resistance to doxorubicin
Author:
Funder
Max-Planck-Gesellschaft
Publisher
Springer Science and Business Media LLC
Subject
General Medicine,Biophysics
Link
http://link.springer.com/content/pdf/10.1007/s00249-016-1149-7.pdf
Reference56 articles.
1. Ashkenazi A et al (1999) Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest 104:155–162. doi: 10.1172/JCI6926
2. Baldwin EL, Osheroff N (2005) Etoposide, topoisomerase II and cancer. Curr Med Chem Anticancer Agents 5:363–372
3. Cheah CY et al (2015) Dulanermin with rituximab in patients with relapsed indolent B-cell lymphoma: an open-label phase 1b/2 randomised study. Lancet Haematol 2:e166–e174. doi: 10.1016/S2352-3026(15)00026-5
4. Clifford B, Beljin M, Stark GR, Taylor WR (2003) G2 arrest in response to topoisomerase II inhibitors: the role of p53. Cancer Res 63:4074–4081
5. de Guadalupe Chavez-Lopez M et al (2015) Astemizole-based anticancer therapy for hepatocellular carcinoma (HCC), and Eag1 channels as potential early-stage markers of HCC. Tumour Biol 36:6149–6158. doi: 10.1007/s13277-015-3299-0
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Potassium channels, tumorigenesis and targeted drugs;Biomedicine & Pharmacotherapy;2023-06
2. Potassium channels: Novel targets for tumor diagnosis and chemoresistance;Frontiers in Oncology;2023-01-10
3. Voltage-Gated Potassium Channels Beyond the Action Potential;Bioelectricity;2022-06-01
4. Technology, Science and Culture: A Global Vision, Volume III;Technology, Science and Culture - A Global Vision, Volume III;2022-05-04
5. Overcoming challenges of HERG potassium channel liability through rational design: Eag1 inhibitors for cancer treatment;Medicinal Research Reviews;2021-05-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3